Literature DB >> 12606905

Risk factors for adverse postoperative outcomes in children presenting for cardiac surgery with upper respiratory tract infections.

Shobha Malviya1, Terri Voepel-Lewis, Monica Siewert, Uma A Pandit, Lori Q Riegger, Alan R Tait.   

Abstract

BACKGROUND: Otherwise healthy children who present for elective surgery with an upper respiratory infection (URI) may be at risk for perioperative respiratory complications. This risk may be increased in children with congenital heart disease who undergo cardiac surgery while harboring a URI because of their compromised cardiopulmonary status. Therefore, this study was designed to determine the incidence of peri- and postoperative complications in children undergoing cardiac surgery while harboring a URI.
METHODS: The study population consisted of 713 children scheduled to undergo cardiac surgery. Of these, 96 had symptoms of URI, and 617 were asymptomatic. Children were followed prospectively from induction of anesthesia to discharge from the hospital to determine the incidence of postoperative respiratory, cardiovascular, neurologic, and surgical adverse events. Duration of postoperative ventilation, time in the intensive care unit (ICU), and length of hospital stay were also recorded.
RESULTS: Children with URIs had a significantly higher incidence of respiratory and multiple postoperative complications than children with no URIs (29.2 vs 17.3% and 25 vs 10.3%, respectively; P< 0.01) and a higher incidence of postoperative bacterial infections (5.2 vs 1.0%; P= 0.01). Furthermore, logistic regression indicated that the presence of a URI was an independent risk factor for multiple postoperative complications and postoperative infections in children undergoing open heart surgery. Children with URIs also stayed longer in the intensive care unit than children with no URIs (75.9 +/- 89.8 h vs 57.7 +/- 63.8, respectively; P< 0.01). However, the overall length of hospital stay was not significantly different (8.4 vs 7.8 days, URI vs non-URI groups; P> 0.05).
CONCLUSIONS: The presence of a URI was predictive of postoperative infection and multiple complications in children presenting for cardiac surgery. Despite this, the presence of a URI does not appear to affect the patient's overall length of hospital stay nor the development of long-term sequelae.

Entities:  

Mesh:

Year:  2003        PMID: 12606905     DOI: 10.1097/00000542-200303000-00009

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  7 in total

Review 1.  Anesthesia and postoperative analgesia in pediatric patients undergoing cardiac surgery.

Authors:  Laura K Diaz
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

2.  The impact of human rhinovirus infection in pediatric patients undergoing heart surgery.

Authors:  Claudia Delgado-Corcoran; Madolin K Witte; Krow Ampofo; Ramon Castillo; Stephanie Bodily; Susan L Bratton
Journal:  Pediatr Cardiol       Date:  2014-06-18       Impact factor: 1.655

3.  Impact of respiratory infection in the results of cardiac surgery in a tertiary hospital in Brazil.

Authors:  Isaac Newton Guimarães Andrade; Diego Torres Aladin de Araújo; Fernando Ribeiro de Moraes Neto
Journal:  Rev Bras Cir Cardiovasc       Date:  2015 Jul-Sep

4.  Flumazenil reduces respiratory complications during anesthesia emergence in children with preoperative upper respiratory tract infections.

Authors:  Ruiqiang Sun; Guolin Wang; Xuesong Gao; Shuzhen Wang
Journal:  Medicine (Baltimore)       Date:  2018-04       Impact factor: 1.889

5.  Impact of early surgical correction or palliation of congenital heart defects in infants with symptomatic viral respiratory tract infections in the current era.

Authors:  Nick A Giffin; Gonzalo Guerra; Joan Robinson; Chloe Joynt; Ivan Rebeyka; V Ben Sivarajan
Journal:  JTCVS Open       Date:  2021-03-26

6.  Respiratory Testing and Hospital Outcomes in Asymptomatic Infants Undergoing Heart Surgery.

Authors:  Claudia Delgado-Corcoran; Anne J Blaschke; Zhining Ou; Angela P Presson; Phillip T Burch; Charles G Pribble; Shaji C Menon
Journal:  Pediatr Cardiol       Date:  2018-10-04       Impact factor: 1.655

7.  COVID-19 convalescent plasma clears SARS-CoV-2 refractory to remdesivir in an infant with congenital heart disease.

Authors:  Zahidee Rodriguez; Andi L Shane; Hans Verkerke; Christopher Lough; Matthew G Zimmerman; Mehul Suthar; Jens Wrammert; Heather MacDonald; Michael Wolf; Shanelle Clarke; John D Roback; Connie M Arthur; Sean R Stowell; Cassandra D Josephson
Journal:  Blood Adv       Date:  2020-09-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.